Pharmabiz

AskBio announces 6 presentations offering insights into R&D of AAV therapies for a range of diseases at ESGCT meeting

Research Triangle Park, North Carolina Saturday, October 4, 2025, 13:00 Hrs [IST] ...
Pharmabiz

Sitryx receives US FDA clearance of IND application for SYX-5219 to treat atopic dermatitis

Sitryx receives US FDA clearance of IND application for SYX-5219 to treat atopic dermatitis: Oxford, UK Saturday, October 4, 2025, 15:30 Hrs [IST] Sitryx Therapeutics, a clinical- ...
Pharmabiz

Draig Therapeutics to initiate phase 2 study of DT-101 for treatment of major depressive disorder

Draig Therapeutics to initiate phase 2 study of DT-101 for treatment of major depressive disorder: Cardiff, UK Saturday, October 4, 2025, 18:00 Hrs [IST] Draig Therapeutics (Draig ...
Pharmabiz

MMS collaborates with Gates Ventures, J&J, AD Data Initiative & GNPC to deliver proteomic datasets for neurodegenerative diseases

MMS collaborates with Gates Ventures, J&J, AD Data Initiative & GNPC to deliver proteomic datasets for neurodegenerative diseases: Canton, Michigan Saturday, October 4, 2025, 15:0 ...
Pharmabiz

AAVantgarde receives US FDA orphan drug designation & UK CTA approval for AAVB-039 to treat Stargardt disease

AAVantgarde receives US FDA orphan drug designation & UK CTA approval for AAVB-039 to treat Stargardt disease: Milan Saturday, October 4, 2025, 17:00 Hrs [IST] AAVantgarde Bio (AA ...
Pharmabiz

India witnessing sharp surge in cases of diabetes across all age brackets: Dr Vijay D’Silva

India witnessing sharp surge in cases of diabetes across all age brackets: Dr Vijay D’Silva: Our Bureau, Mumbai Saturday, October 4, 2025, 14:30 Hrs [IST] Branded the “diabete ...
Pharmabiz

Amgen’s phase 3 VESALIUS-CV trial meets primary endpoints in a cardiovascular primary prevention study of 12,000 patients

Amgen’s phase 3 VESALIUS-CV trial meets primary endpoints in a cardiovascular primary prevention study of 12,000 patients: Thousand Oaks, California Saturday, October 4, 2025, 1 ...
Pharmabiz

Lupin launches liraglutide injection in US markets

Global pharma major Lupin Limited (Lupin) announced the launch of liraglutide injection, 18 mg/3 mL (6 mg/mL) single-patient-use prefilled pen, in the United States. Liraglutide injection, 18 mg/3 mL ...
Pharmabiz

Indian Pharmaceutical Alliance appoints Dr Sharvil Patel as president and Glenn Saldanha as vice president

Indian Pharmaceutical Alliance appoints Dr Sharvil Patel as president and Glenn Saldanha as vice president: Our Bureau, Mumbai Saturday, October 4, 2025, 14:15 Hrs [IST] The India ...
Pharmabiz

TN FDA finds cough syrup with DEG beyond permissible limit

Even as the Central Drugs Standard Control Organisation's (CDSCO) found that the cough syrup samples it tested from Madhya Pradesh free from diethylene glycol (DEG) or ethylene glycol (EG), samples of ...
Pharmabiz

Illumina launches BioInsight, a new business to accelerate technology and data-driven discovery

Illumina launches BioInsight, a new business to accelerate technology and data-driven discovery: San Diego Saturday, October 4, 2025, 14:00 Hrs [IST] Illumina, Inc., a global geno ...
Pharmabiz

EMA advices on end-of-year submission dates for type I variations in 2025

EMA advices on end-of-year submission dates for type I variations in 2025: Amsterdam, The Netherlands Saturday, October 4, 2025, 16:00 Hrs [IST] EMA is advising marketing authoris ...